Prevention and treatment of epstein–barr virus‐associated lymphoproliferative disorders in recipients of bone marrow and solid organ transplants

van Gorp, J., Doornewaard, H. , Verdonck, L.F. , Klopping, C. , Vos, P.F. & van den Tweel, J.G. (1994) Posttransplant T cell lymphoma. Cancer, 73, 3064–3072. Gottschalk, S. , Ng, C.Y. C. , Perez, M. , Smith, C.A. , Sample, C. , Brenner, M.K. , Heslop, H.E. & Rooney, C.M. (2001) An Epstein– Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood, 97, 835–843. Gratama, J.W. , Oosterveer, M.A.P., Zwaan, F.E. , Lepoutre, J., Klein, G. & Ernberg, I. (1988) Eradication of Epstein–Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proceedings of the National Academy of Science of the United States of America, 85, 8693–8696. Gratama, J.W. , Lenette, E.T. , Lonnqvist, M.A.P., Klein, G. , Ringden, O. & Ernberg, I. (1992) Detection of multiple Epstein–Barr viral strains in allogeneic bone marrow transplantation. Journal of Medical Virology, 37, 39–47. Green, M. , Kaufmann. M. , Wilson, J. & Reyes, J. (1997) Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein–Barr virus disease after liver transplantation in children. Clinical Infectious Diseases, 25, 1344–1349. Gross, T.G. , Hinrichs, S.H. , Davis, J.R. , Mitchell, D. , Bishop, M.R. & Wagner, J.E. (1998) Depletion of EBV-infected cells in donor marrow by counterflow elutriation. Experimental Hematology, 26, 395–399. Gross, T.G. , Steinbuch, M. , DeFor, T. , Shapiro, R.S. , McGlave, P., Ramsay, N.K. C. , Wagner, J.E. & Filipovich, A.H. (1999) B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplantation, 23, 251–258. Gruhn, B. , Meerbach, A. , Egerer, R. , Mentzel, H.J., Hafer, R. , Ringelmann, F. , Sauerm, M. , Hermann, J. & Zintl, F. (1999) Successful treatment of Epstein–Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantation. Bone Marrow Transplantation, 24, 1355–1358. Gruhn, B. , Meerbach, A. , Hafer, R. , Zell, R. , Berndt, A. , Kosmehl, H. , Wutzler, P. & Zintl, F. (2001) Early diagnosis and pre-emptive therapy of Epstein–Barr virus-associated lymphoproliferative disease following hematopoietic stem cell transplantation. Blood, 98, S393a. Abstract. Gustafsson, A. , Levitsky, V. , Frisan, T. , Dalianis, T. , Ljungman, P., Ringden, O. , Winiarski, J., Emberg, I. & Masucci, M.G. (2000) Epstein–Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T-cells. Blood, 95, 807–814. Hale, G. & Waldmann, H. (1998) Risks of developing Epstein–Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. Blood, 91, 3079–3083. Hanel, M. , Fiedler, F. & Thorns, C. (2001) Anti-CD20 monoclonal antibody (rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie, 24, 491–494. Haque, T. & Crawford, D.H. (1999) The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation. British Journal of Haematology, 106, 309–316. Haque, T. , Thomas, J.A. , Falk, K.I. , Parratt, R. , Hunt, B.J., Yacoub, M. & Crawford, D.H. (1996) Transmission of donor Epstein–Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. Journal of General Virology,